Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Date
Availability
1-2 of 2
Keywords: drug screening
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Audrey Colomba, Martina Fitzek, Roger George, Gregory Weitsman, Selene Roberts, Laura Zanetti-Domingues, Michael Hirsch, Daniel J. Rolfe, Shahid Mehmood, Andrew Madin, Jeroen Claus, Svend Kjaer, Ambrosius P. Snijders, Tony Ng, Marisa Martin-Fernandez, David M. Smith, Peter J. Parker
Journal:
Biochemical Journal
Biochem J (2020) 477 (17): 3329–3347.
Published: 10 September 2020
... for this article was enabled by the participation of The Francis Crick Institute in an all-inclusive Read & Publish pilot with Portland Press and the Biochemical Society under a transformative agreement with JISC. allostery drug screening HER3 inhibitor pseudokinases Pseudokinases belong...
Includes: Multimedia, Supplementary data
Articles
Catherine E. Scull, Yinfeng Zhang, Nichole Tower, Lynn Rasmussen, Indira Padmalayam, Robert Hunter, Ling Zhai, Robert Bostwick, David A. Schneider
Journal:
Biochemical Journal
Biochem J (2019) 476 (15): 2209–2219.
Published: 09 August 2019
... malignant melanoma cells in vitro . Furthermore, acute, transient treatment with RBI2 inhibits anchorage-independent cell growth and proliferation. These studies validate our screening strategy and identify two promising compounds for further pre-clinical development. cancer drug screening...
Includes: Supplementary data
